St. Jude Children's Research Hospital: Novel Beta-Thalassemia Treatment Shows Promise in Preclinical Tests
August 21, 2019
August 21, 2019
MEMPHIS, Tennessee, Aug. 21 -- St. Jude Children's Research Hospital issued the following news release:
* * *
- St. Jude Children's Research Hospital researchers have identified a possible new use for the drug rapamycin: Activating a cellular pathway to reduce accumulation of a toxic protein that is a hallmark of Beta-thalassemia.
* * *
Rapamycin, a drug widely used to protect organ transplant patients, eased symptoms of Beta-thalassemia in mic . . .
* * *
- St. Jude Children's Research Hospital researchers have identified a possible new use for the drug rapamycin: Activating a cellular pathway to reduce accumulation of a toxic protein that is a hallmark of Beta-thalassemia.
* * *
Rapamycin, a drug widely used to protect organ transplant patients, eased symptoms of Beta-thalassemia in mic . . .